222 related articles for article (PubMed ID: 35615153)
41. The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis.
Wang Z; Ni Y; Chen J; Sun G; Zhang X; Zhao J; Zhu X; Zhang H; Zhu S; Dai J; Shen P; Zeng H
World J Surg Oncol; 2020 Feb; 18(1):42. PubMed ID: 32093688
[TBL] [Abstract][Full Text] [Related]
42. The Impact of Neoadjuvant Hormone Therapy on Surgical and Oncological Outcomes for Patients With Prostate Cancer Before Radical Prostatectomy: A Systematic Review and Meta-Analysis.
Zhang L; Zhao H; Wu B; Zha Z; Yuan J; Feng Y
Front Oncol; 2020; 10():615801. PubMed ID: 33628732
[TBL] [Abstract][Full Text] [Related]
43. Evidence on Statins, Omega-3, and Prostate Cancer: A Narrative Review.
Kim H; Kim JK
World J Mens Health; 2022 Jul; 40(3):412-424. PubMed ID: 35021299
[TBL] [Abstract][Full Text] [Related]
44. The significance of De Ritis ratio in patients with radiation-recurrent prostate cancer undergoing salvage radical prostatectomy.
Quhal F; Abufaraj M; Janisch F; Mori K; Lysenko I; Mostafaei H; D'Andrea D; Mathieu R; Enikeev DV; Fajkovic H; Heidenreich A; Shariat SF
Arab J Urol; 2020 May; 18(4):213-218. PubMed ID: 33312731
[TBL] [Abstract][Full Text] [Related]
45. Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients.
Wan S; Huang C; Zhu X
BMJ Open; 2019 Jul; 9(7):e030038. PubMed ID: 31315875
[TBL] [Abstract][Full Text] [Related]
46. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Rieken M; Kluth LA; Xylinas E; Seitz C; Fajkovic H; Karakiewicz PI; Lotan Y; Briganti A; Loidl W; Faison T; Crivelli JJ; Scherr DS; Bachmann A; Tewari AK; Kautzky-Willer A; Pummer K; Shariat SF
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):367-71. PubMed ID: 23999669
[TBL] [Abstract][Full Text] [Related]
47. The Suggested Unique Association Between the Various Statin Subgroups and Prostate Cancer.
Goldberg H; Mohsin FK; Saskin R; Kulkarni GS; Berlin A; Kenk M; Wallis CJD; Klaassen Z; Chandrasekar T; Ahmad AE; Sayyid RK; Saarela O; Penn L; Alibhai SMH; Fleshner N
Eur Urol Focus; 2021 May; 7(3):537-545. PubMed ID: 32620539
[TBL] [Abstract][Full Text] [Related]
48. Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis.
Kardoust Parizi M; Abufaraj M; Fajkovic H; Kimura S; Iwata T; D'Andrea D; Karakiewicz PI; Shariat SF
Urol Oncol; 2019 Oct; 37(10):637-646. PubMed ID: 31296421
[TBL] [Abstract][Full Text] [Related]
49. Impact of biopsy perineural invasion on the outcomes of patients who underwent radical prostatectomy: a systematic review and meta-analysis.
Wu S; Lin X; Lin SX; Lu M; Deng T; Wang Z; Olumi AF; Dahl DM; Wang D; Blute ML; Wu CL
Scand J Urol; 2019 Oct; 53(5):287-294. PubMed ID: 31401922
[No Abstract] [Full Text] [Related]
50. The Clinicopathologic and Prognostic Significance of Programmed Cell Death Ligand 1 (PD-L1) Expression in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.
Li Y; Huang Q; Zhou Y; He M; Chen J; Gao Y; Wang X
Front Pharmacol; 2018; 9():1494. PubMed ID: 30733677
[No Abstract] [Full Text] [Related]
51. PITX2 methylation: a novel and effective biomarker for monitoring biochemical recurrence risk of prostate cancer.
Jiang Q; Xie M; He M; Yan F; Chen M; Xu S; Zhang X; Shen P
Medicine (Baltimore); 2019 Jan; 98(1):e13820. PubMed ID: 30608394
[TBL] [Abstract][Full Text] [Related]
52. Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Vyas A; Salkini M; Madhavan S; Sambamoorthi U
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):110-21. PubMed ID: 25667109
[TBL] [Abstract][Full Text] [Related]
53. Statin use and prognosis of lung cancer: a systematic review and meta-analysis of observational studies and randomized controlled trials.
Xia DK; Hu ZG; Tian YF; Zeng FJ
Drug Des Devel Ther; 2019; 13():405-422. PubMed ID: 30774306
[TBL] [Abstract][Full Text] [Related]
54. Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis.
Wu Y; Qu X; Wang Y; Xia J; Gu Y; Qian Q; Hong Y
Andrologia; 2019 Mar; 51(2):e13198. PubMed ID: 30443968
[TBL] [Abstract][Full Text] [Related]
55. Do tumor volume, percent tumor volume predict biochemical recurrence after radical prostatectomy? A meta-analysis.
Meng Y; Li H; Xu P; Wang J
Int J Clin Exp Med; 2015; 8(12):22319-27. PubMed ID: 26885209
[TBL] [Abstract][Full Text] [Related]
56. Use of Concomitant Androgen Deprivation Therapy in Patients Treated with Early Salvage Radiotherapy for Biochemical Recurrence After Radical Prostatectomy: Long-term Results from a Large, Multi-institutional Series.
Gandaglia G; Fossati N; Karnes RJ; Boorjian SA; Colicchia M; Bossi A; Seisen T; Cozzarini C; Di Muzio N; Noris Chiorda B; Zaffuto E; Wiegel T; Shariat SF; Goldner G; Joniau S; Battaglia A; Haustermans K; De Meerleer G; Fonteyne V; Ost P; Van Poppel H; Montorsi F; Briganti A
Eur Urol; 2018 Apr; 73(4):512-518. PubMed ID: 29229176
[TBL] [Abstract][Full Text] [Related]
57. Prognostic Value of Gleason Score at Positive Surgical Margin in Prostate Cancer: A Systematic Review and Meta-analysis.
Lysenko I; Mori K; Mostafaei H; Enikeev DV; Karakiewicz PI; Briganti A; Quhal F; Janisch F; Shariat SF
Clin Genitourin Cancer; 2020 Oct; 18(5):e517-e522. PubMed ID: 32229268
[TBL] [Abstract][Full Text] [Related]
58. Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure.
Jackson WC; Suresh K; Tumati V; Dess RT; Soni PD; Zhao SG; Zumsteg ZS; Hannan R; Hollenbeck BK; George A; Kaffenberger SD; Salami SS; Hearn JWD; Morgan TM; Mehra R; Schipper M; Feng FY; Desai NB; Spratt DE
Eur Urol Oncol; 2018 Sep; 1(4):276-282. PubMed ID: 31100248
[TBL] [Abstract][Full Text] [Related]
59. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
60. Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies.
Islam MM; Poly TN; Walther BA; Yang HC; Jack Li YC
Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32183029
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
